These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25394116)

  • 1. High rates of viral suppression in a cohort of HIV-positive adults receiving ART in Ethiopian health centers irrespective of concomitant tuberculosis.
    Reepalu A; Balcha TT; Skogmar S; Jemal ZH; Sturegård E; Medstrand P; Björkman P
    J Int AIDS Soc; 2014; 17(4 Suppl 3):19612. PubMed ID: 25394116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High rates of virological suppression in a cohort of human immunodeficiency virus-positive adults receiving antiretroviral therapy in ethiopian health centers irrespective of concomitant tuberculosis.
    Reepalu A; Balcha TT; Skogmar S; Jemal ZH; Sturegård E; Medstrand P; Björkman P
    Open Forum Infect Dis; 2014 Mar; 1(1):ofu039. PubMed ID: 25734107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-γ-Inducible Protein 10 (IP-10) Kinetics after Antiretroviral Treatment Initiation in Ethiopian Adults with HIV.
    Thorman J; Björkman P; Marrone G; Tolera Balcha T; Tesfaye F; Abdissa T; Naniche D; Medstrand P; Reepalu A
    Microbiol Spectr; 2021 Dec; 9(3):e0181021. PubMed ID: 34908450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcome of Antiretroviral Treatment in Patients With and Without Concomitant Tuberculosis Receiving Health Center-Based Care-Results From a Prospective Cohort Study.
    Reepalu A; Balcha TT; Sturegård E; Medstrand P; Björkman P
    Open Forum Infect Dis; 2017; 4(4):ofx219. PubMed ID: 29226173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated with Early Mortality in HIV-Positive Men and Women Investigated for Tuberculosis at Ethiopian Health Centers.
    Reepalu A; Balcha TT; Skogmar S; Güner N; Sturegård E; Björkman P
    PLoS One; 2016; 11(6):e0156602. PubMed ID: 27272622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Chimsuntorn S; Sungkanuparph S
    HIV Med; 2008 May; 9(5):294-9. PubMed ID: 18400076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of HIV-infected tuberculosis patients in Thailand.
    Mankatittham W; Likanonsakul S; Thawornwan U; Kongsanan P; Kittikraisak W; Burapat C; Akksilp S; Sattayawuthipong W; Srinak C; Nateniyom S; Tasaneeyapan T; Varma JK
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):93-103. PubMed ID: 19323040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral treatment failure predicts mortality in rural Tanzania.
    Pettersen PS; Brox IK; Naman E; Bruun JN; Dyrhol-Riise AM; Trøseid M; Johannessen A
    Int J STD AIDS; 2015 Aug; 26(9):633-9. PubMed ID: 25122578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latent Tuberculosis Infection Screening and 2-Year Outcome in Antiretroviral-Naive HIV-Infected Patients in a Low-Prevalence Country.
    Bourgarit A; Baron G; Breton G; Tattevin P; Katlama C; Allavena C; Campa P; Ravaud P; Lortholary O; Carcelain G;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1138-45. PubMed ID: 26213798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of lipoarabinomannan in urine for identification of active tuberculosis among HIV-positive adults in Ethiopian health centres.
    Balcha TT; Winqvist N; Sturegård E; Skogmar S; Reepalu A; Jemal ZH; Tibesso G; Schön T; Björkman P
    Trop Med Int Health; 2014 Jun; 19(6):734-742. PubMed ID: 24684481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
    van Griensven J; Choun K; Chim B; Thai S; Lorent N; Lynen L
    Trop Med Int Health; 2015 Dec; 20(12):1823-31. PubMed ID: 26426387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of antiretroviral therapy in advanced AIDS with active tuberculosis: clinical experiences from Thailand.
    Sungkanuparph S; Manosuthi W; Kiertiburanakul S; Vibhagool A
    J Infect; 2006 Mar; 52(3):188-94. PubMed ID: 15992932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier initiation of antiretroviral therapy, increased tuberculosis case finding and reduced mortality in a setting of improved HIV care: a retrospective cohort study.
    Hermans SM; van Leth F; Manabe YC; Hoepelman AI; Lange JM; Kambugu A
    HIV Med; 2012 Jul; 13(6):337-44. PubMed ID: 22296211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors and Timing of ATT Initiation among HIV-TB Patients at ART Centers of Karnataka, India: Two Year Follow-Up.
    Shastri S; Nagaraja SB; Tripathy JP; Satyanarayana S; Rewari BB
    PLoS One; 2015; 10(9):e0138603. PubMed ID: 26394397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Scoring Algorithm for Determination of the Risk of Tuberculosis in HIV-Infected Adults: A Cohort Study Performed at Ethiopian Health Centers.
    Balcha TT; Skogmar S; Sturegård E; Schön T; Winqvist N; Reepalu A; Jemal ZH; Tibesso G; Björk J; Björkman P
    Open Forum Infect Dis; 2014 Dec; 1(3):ofu095. PubMed ID: 25734163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of CD4+ T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression.
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA
    AIDS Res Hum Retroviruses; 2009 Jun; 25(6):756-76. PubMed ID: 19500017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries.
    Pujades-Rodríguez M; Balkan S; Arnould L; Brinkhof MA; Calmy A;
    JAMA; 2010 Jul; 304(3):303-12. PubMed ID: 20639564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.